Overview
Background
Prof Michael Barras is the Director of Pharmacy at the Princess Alexandra Hospital and a Research conjoint with the School of Pharmacy (Hospital 0.8 FTE / UQ 0.2 FTE). He currently supervises 8 HDR students who are conducting research related to medication safety, health informatics and advanced scope clinical pharmacy. He has a strong interest in designing, testing and monitoring individualised dosing strategies for high-risk patients in the hospital setting. Michael has many significant research relationships in hospital, university, and industry settings. He is a member of the SoP research committee.
Availability
- Professor Michael Barras is:
- Not available for supervision
Works
Search Professor Michael Barras’s works on UQ eSpace
2017
Journal Article
A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation
Nakagaki, Midori, Barras, Michael, Curley, Cameron, Butler, Jason P. and Kennedy, Glen A. (2017). A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation. Supportive Care in Cancer, 25 (2), 1-7. doi: 10.1007/s00520-016-3445-2
2017
Conference Publication
Identifying Clinical Pharmacist Patient Prioritisation Criteria
Falconer, Nazanin, Barras, Michael and Cottrell, Neil (2017). Identifying Clinical Pharmacist Patient Prioritisation Criteria. Australasian Pharmaceutical Science Association (APSA) and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Joint Scientific Meeting, Brisbane QLD Australia, December 2017.
2017
Conference Publication
The influence of sampling time on estimated tobramycin exposure in patient with cystic fibrosis
Gao, Yanhua, Hennig, Stefanie and Barras, Michael (2017). The influence of sampling time on estimated tobramycin exposure in patient with cystic fibrosis. Australian Society of Clinical Pharmacology and Toxicology National Conference, Brisbane, QLD, Australia, 5 – 8 December 2017.
2017
Conference Publication
Identifying inpatients at high risk of adverse drug events: Systematic review of predictive risk scores
Falconer, Nazanin, Barras, Michael and Cottrell, Neil (2017). Identifying inpatients at high risk of adverse drug events: Systematic review of predictive risk scores. Society of Hospital Pharmacists of Australia conference, Sydney, Australia, November 2017.
2017
Journal Article
Drug dosing in obese adults
Barras, Michael and Legg, Amy (2017). Drug dosing in obese adults. Australian Prescriber, 40 (5), 189-193. doi: 10.18773/austprescr.2017.053
2016
Journal Article
Bayesian estimation of tobramycin exposure in cystic fibrosis
Barras, Michael A., Serisier, David, Hennig, Stefanie, Jess, Katrina and Norris, Ross L. G. (2016). Bayesian estimation of tobramycin exposure in cystic fibrosis. Antimicrobial Agents and Chemotherapy, 60 (11), 6698-6702. doi: 10.1128/AAC.01131-16
2016
Journal Article
Inpatient smoking cessation – turn to your clinical pharmacist
Snoswell, Centaine and Barras, Michael (2016). Inpatient smoking cessation – turn to your clinical pharmacist. Australian and New Zealand Journal of Public Health, 40 (5), 498-498. doi: 10.1111/1753-6405.12567
2016
Journal Article
Direct oral anticoagulants: new drugs with practical problems. How can nurses help prevent patient harm?
Barras, Michael A., Hughes, David and Ullner, Melanie (2016). Direct oral anticoagulants: new drugs with practical problems. How can nurses help prevent patient harm?. Nursing and Health Sciences, 18 (3), 408-411. doi: 10.1111/nhs.12263
2016
Journal Article
Examining hospital pharmacists' goals for medication counselling within the communication accommodation theoretical framework
Chevalier, Bernadette A. M., Watson, Bernadette M., Barras, Michael A. and Cottrell, William Neil (2016). Examining hospital pharmacists' goals for medication counselling within the communication accommodation theoretical framework. Research in Social and Administrative Pharmacy, 12 (5), 747-755. doi: 10.1016/j.sapharm.2015.10.008
2016
Journal Article
New oral anticoagulants: appropriateness of prescribing in real-world setting
Pattullo, C. S., Barras, M., Tai, B., McKean, M. and Donovan, P. (2016). New oral anticoagulants: appropriateness of prescribing in real-world setting. Internal Medicine Journal, 46 (7), 812-818. doi: 10.1111/imj.13118
2016
Journal Article
Evaluation of therapeutic enoxaparin in a pregnant population at a tertiary hospital
Petrie, S., Barras, M., Lust, K., Fagermo, N., Allen, J. and Martin, J. H. (2016). Evaluation of therapeutic enoxaparin in a pregnant population at a tertiary hospital. Internal Medicine Journal, 46 (7), 826-833. doi: 10.1111/imj.13117
2016
Journal Article
Compliance with enoxaparin dosing and monitoring guidelines and the impact on patient length of stay: a pilot study
Dekker, Katharine R., Myers, Brooke L. and Barras, Michael A. (2016). Compliance with enoxaparin dosing and monitoring guidelines and the impact on patient length of stay: a pilot study. Therapeutic Drug Monitoring, 38 (1), 59-63. doi: 10.1097/FTD.0000000000000233
2016
Journal Article
Effects of a pilot multidisciplinary clinic for frequent attending elderly patients on deprescribing
Mudge, Alison, Radnedge, Katherine, Kasper, Karen, Mullins, Robert, Adsett, Julie, Rofail, Serena, Lloyd, Sophie and Barras, Michael (2016). Effects of a pilot multidisciplinary clinic for frequent attending elderly patients on deprescribing. Australian Health Review, 40 (1), 86-91. doi: 10.1071/AH14219
2015
Journal Article
A randomized trial of olanzapine and palonosetron versus infused ondansetron for the treatment of chemotherapy induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation
Nakagaki, Midori, Barras, Michael, Curley, Cameron, Butler, Jason P and Kennedy, Glen A (2015). A randomized trial of olanzapine and palonosetron versus infused ondansetron for the treatment of chemotherapy induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation. Blood, 126 (23), 1910-1910. doi: 10.1182/blood.v126.23.1910.1910
2015
Conference Publication
A Randomized Trial of Olanzapine and Palonosetron versus Infused Ondansetron for the Treatment of Chemotherapy Induced Nausea and Vomiting in Patients Undergoing Hematopoietic Stem Cell Transplantation
Nakagaki, Midori, Barras, Michael, Curley, Cameron, Butler, Jason P. and Kennedy, Glen A. (2015). A Randomized Trial of Olanzapine and Palonosetron versus Infused Ondansetron for the Treatment of Chemotherapy Induced Nausea and Vomiting in Patients Undergoing Hematopoietic Stem Cell Transplantation. 57th Annual Meeting of the American Society of Hematology, Orlando, FL United States, 5-8 December 2015. Washington, DC United States: American Society of Hematology.
2015
Journal Article
Hospital pharmacists' perceptions of medication counseling: a focus group study
Chevalier, Bernadette A. M., Watson, Bernadette M., Barras, Michael A. and Cottrell, William Neill (2015). Hospital pharmacists' perceptions of medication counseling: a focus group study. Research in Social and Administrative Pharmacy, 12 (5), 756-771. doi: 10.1016/j.sapharm.2015.10.007
2015
Journal Article
Facing the challenges of new melanoma-targeted therapies: treatment of severe fevers associated with dabrafenib/trametinib combination therapy
Lindsay, Julian N. and Barras, Michael (2015). Facing the challenges of new melanoma-targeted therapies: treatment of severe fevers associated with dabrafenib/trametinib combination therapy. Journal of Oncology Pharmacy Practice, 21 (4), 293-295. doi: 10.1177/1078155214527859
2015
Journal Article
Comparison of 2 weight-based heparin dosing nomograms in neurology and vascular surgical patients
Marotti, Sally B., Barras, Michael and Kirkpatrick, Carl (2015). Comparison of 2 weight-based heparin dosing nomograms in neurology and vascular surgical patients. Therapeutic Drug Monitoring, 37 (1), 33-39. doi: 10.1097/FTD.0000000000000099
2015
Book Chapter
Peri-procedural anticoagulation
Barras, Michael (2015). Peri-procedural anticoagulation. Anticoagulation management: a guide for pharmacists . (pp. 179-199) edited by Anne Rose. Cham, Switzerland: Springer International Publishing. doi: 10.1007/978-3-319-22602-6_8
2015
Journal Article
Engaging pharmacists in clinical research
Barras, Michael (2015). Engaging pharmacists in clinical research. Australian Journal of Pharmacy, 96 (1139)
Supervision
Availability
- Professor Michael Barras is:
- Not available for supervision
Supervision history
Current supervision
-
Doctor Philosophy
A pharmacist to improve medication management and patient outcomes for critically ill patients in the emergency department.
Principal Advisor
Other advisors: Dr Nazanin Ghahreman-Falconer, Associate Professor Katherine Isoardi
-
Doctor Philosophy
A predictive model for 30-day hospital readmission in Cardiology patients
Principal Advisor
Other advisors: Professor Ian Coombes, Dr Nazanin Ghahreman-Falconer
-
Doctor Philosophy
Patient-Centred Pharmacy Care in the hospital setting
Principal Advisor
Other advisors: Professor Ian Coombes, Dr Nazanin Ghahreman-Falconer
-
Master Philosophy
Pharmacist led post discharge medication review in patients at high-risk of medication related harm
Associate Advisor
Other advisors: Dr Carla Scuderi, Professor Ian Coombes, Dr Nazanin Ghahreman-Falconer
-
Doctor Philosophy
Implementing a Medication review pharmacy clinic and the potential impact on patient care.
Associate Advisor
Other advisors: Dr Centaine Snoswell, Dr Holly Foot
-
Doctor Philosophy
Improving the perioperative management of therapeutically anticoagulated patients during major orthopaedic surgery
Associate Advisor
Other advisors: Professor Lisa Nissen, Associate Professor Esther Lau
-
Doctor Philosophy
Voluntary assisted dying services in Queensland
Associate Advisor
Other advisors: Associate Professor Adam La Caze
-
Doctor Philosophy
Development and Integration of a Medication Harm Prediction Tool within an Australian Digital Hospital
Associate Advisor
Other advisors: Professor Ian Scott, Dr Nazanin Ghahreman-Falconer
-
Doctor Philosophy
Quality and Safe Use of Clozapine
Associate Advisor
Other advisors: Associate Professor Nicola Warren, Professor Steve Kisely, Professor Dan Siskind
-
Doctor Philosophy
Evaluation of a predictive model for dosing IV unfractionated heparin developed using machine learning
Associate Advisor
Other advisors: Dr Nazanin Ghahreman-Falconer
Completed supervision
-
2024
Doctor Philosophy
Exploring the impact of electronic medication management on the safety and quality of therapeutic anticoagulation
Principal Advisor
Other advisors: Professor Clair Sullivan, Dr Lee Woods
-
2024
Doctor Philosophy
Medication harm in patients after acute myocardial infarction
Principal Advisor
Other advisors: Professor Ian Coombes
-
2022
Doctor Philosophy
Aspirin for the Prophylaxis of Venous Thromboembolic Events
Associate Advisor
-
2022
Doctor Philosophy
Cellular studies on the role of matrix dependent mechanism of atherosclerosis: role of transcription factor Smad and its phosphorylation
Associate Advisor
-
2020
Doctor Philosophy
Prioritising patients at high-risk of medication harm: Development and validation of risk prediction models
Associate Advisor
-
2017
Doctor Philosophy
Investigating the effectiveness of communication taking place between hospital pharmacists and patients during medication counselling
Associate Advisor
Other advisors: Honorary Professor Bernadette Watson
Media
Enquiries
For media enquiries about Professor Michael Barras's areas of expertise, story ideas and help finding experts, contact our Media team: